Hiroyuki Yamada

Hiroyuki Yamada

Auto-generated profile, based on publicly available information

Hiroyuki Yamada

Affiliation Department of Otolaryngology, Head and Neck Surgery, Ehime University Graduate School of Medicine, Toon, Japan

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2021 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
PDF file
SMSohei Mitani
Sohei Mitani
ESEriko Sato
Eriko Sato
NKNaoto Kawaguchi
Naoto Kawaguchi
SSShun Sawada
Shun Sawada
KSKayo Sakamoto
Kayo Sakamoto
NHNaohito Hato
Naohito Hato
Objective: We report our first experience of using a case‐specific three‐dimensional (3D) hologram for tumor resection in otolaryngology to show the proof of concept. In addition, a questionnaire was administered to assess the usefulness of the mixed reality technique in otolaryngology.Methods: A case‐specific 3D hologram was developed from enhanced images of dynamic computed tomography, with reference to contrast‐enhanced magnetic resonance images, and used for preoperative planning and intraoperative image reference. To evaluate the usefulness of the 3D hologram with head mount displays (HMDs), 18 attendings and resident otolaryngologists completed a questionnaire with the Likert scale.Results: The case‐specific 3D hologram on HMDs was successfully used by means of easy gesture‐handling without any monitors preoperatively and intraoperatively. The experience of picturing the tumor localization and evaluating the surgical approach was statistically better using the 3D hologram on HMDs than using the computer images (P < .01). Similarly, the holograms were observed to be better for intraoperative application and surgical education than computer images (P < .01).Conclusion: We demonstrated the use of a case‐specific 3D hologram for tumor resection in otolaryngology. The technology may be useful for preoperative planning and intraoperative image reference, especially for challenging cases, and surgical education.Level of Evidence: NA.

25 July 2019 in Ear & Hearing
Verified
Journal Article
Closed access
Yoshihiro MiyakeYoshihiro Miyake
Yoshihiro Miyake
KTKeiko Tanaka
Keiko Tanaka
HSHidenori Senba
Hidenori Senba
SOSusumu Ogawa
Susumu Ogawa
HSHiroyuki Suzuki
Hiroyuki Suzuki
NHNaohito Hato
Naohito Hato
Objectives: Hearing impairment (HI) in midlife may increase the risk of dementia. However, epidemiological research on the association between HI and mild cognitive impairment (MCI) is very limited. Design: The present cross-sectional study investigated the relationship between HI and MCI using baseline data from the Aidai Cohort Study. Study subjects were 995 Japanese adults aged 36 to 84 years. We used the audiometric definition of HI adopted by the World Health Organization, which identifies the speech-frequency pure-tone average hearing thresholds at 0.5, 1, 2, and 4 kHz tones. HI was defined as present when pure-tone average was >25 dB HL in the better hearing ear. MCI was defined as being present when a subject had a Japanese version of the Montreal Cognitive Assessment score of <26. Adjustment was made for age, sex, smoking status, alcohol consumption, leisure time physical activity, hypertension, dyslipidemia, diabetes mellitus, history of depression, body mass index, waist circumference, employment, education, and household income. Results: Among the 995 study subjects, the prevalence values of HI and MCI were 24.3% and 44.5%, respectively. HI was independently positively associated with MCI: the multivariate-adjusted odds ratio (95% confidence interval) was 1.86 (1.32 to 2.62). HI was independently related to a higher prevalence of MCI in those aged 60 to 69 years and those aged 70 years or older: the multivariate-adjusted odds ratios (95% confidence intervals) were 1.64 (1.03 to 2.62) and 2.30 (1.04 to 5.27), respectively. Conclusions: HI may be associated with a higher prevalence of MCI.

1 October 2020 in Auris Nasus Larynx
Verified
Journal Article
Closed access
TJTomonori Joko
Tomonori Joko
HYHiroyuki Yamada
Hiroyuki Yamada
TKTakuya Kimura
Takuya Kimura
MTMasato Teraoka
Masato Teraoka
NHNaohito Hato
Naohito Hato

1 February 2019 in Auris Nasus Larynx
Verified
Journal Article
Closed access
DBDavid Bächinger
David Bächinger
DTDaiki Takagi
Daiki Takagi
HYHiroyuki Yamada
Hiroyuki Yamada
MTMasato Teraoka
Masato Teraoka
MOMasahiro Okada
Masahiro Okada
NHNaohito Hato
Naohito Hato

1 February 2019 in Auris Nasus Larynx
Verified
Journal Article
Closed access
MOMasahiro Okada
Masahiro Okada
KSKoichiro Suemori
Koichiro Suemori
DTDaiki Takagi
Daiki Takagi
MTMasato Teraoka
Masato Teraoka
HYHiroyuki Yamada
Hiroyuki Yamada
NHNaohito Hato
Naohito Hato

1 July 2021 in Otology & Neurotology
Verified
Journal Article
Closed access
TKTakuya Kimura
Takuya Kimura
HYHiroyuki Yamada
Hiroyuki Yamada
MTMasato Teraoka
Masato Teraoka
TJTomonori Joko
Tomonori Joko
SIShinji Iwata
Shinji Iwata
NHNaohito Hato
Naohito Hato
Hypothesis: We investigated the treatment effect of intratympanic insulin-like growth factor-1 (IGF-1) on severe facial paralysis in guinea pigs. Background: The use of regenerative medicine involving growth factors has been reported in the treatment of peripheral nerve diseases. IGF-1 plays a crucial role in nerve regeneration. Methods: We performed the following procedures on guinea pigs. In the normal group (n = 7), no procedure was performed. In the saline (n = 7) and IGF-1 (n = 7) groups, facial paralysis was induced by freezing of the facial canal. Subsequently, in the saline and IGF-1 groups, a gelatin hydrogel impregnated with 100 μL saline and 400 μg/100 μL IGF-1, respectively, was placed in the facial canal. Facial nerve functions were evaluated using three test batteries: facial movement observation, electrophysiological testing, and histological assessment. Results: At 10 weeks postoperatively, the facial movement scores for the IGF-1 group were improved compared to those in the saline group. The conductive velocity was significantly faster in the IGF-1 group than in the saline group. There was a significant between-group difference in the nerve fiber number and myelin thickness. Conclusion: Intratympanic IGF-1 administration improved facial nerve regeneration. This novel method could provide prompt ambulatory regenerative treatment and reduce the incidence of poor recovery in patients with severe facial paralysis.